| Title |
|
Hypocalcemia induced by raloxifene. |
|
|
| Publication Date |
|
| Author(s) |
|
| Type of document |
|
| Abstract |
|
Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy. |
|
|
| Link |
|
| Citation |
|
Current Drug Safety; 7(2): 176-8 |
|
|
| Jornal Title |
|
